GenMark Diagnostics, Inc.·4

Jan 22, 7:35 PM ET

McNally James B. 4

4 · GenMark Diagnostics, Inc. · Filed Jan 22, 2019

Insider Transaction Report

Form 4
Period: 2019-01-17
McNally James B.
SVP, Marketing & Bus Dev
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-17+11,428180,222 total
  • Exercise/Conversion

    Market Stock Units

    2019-01-17+11,42819,822 total
    Exercise: $0.00Common Stock (11,428 underlying)
Footnotes (2)
  • [F1]Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index.
  • [F2]The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index.

Documents

1 file
  • 4
    wf-form4_154820371177557.xmlPrimary

    FORM 4